Nu Skin Enterprises, Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses), averaging -3.3% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.20 | $0.20 | +0.0% | Beat | Q2 FY26 call |
| Q1 FY26 | $0.15 | $0.14 | -6.7% | Miss |
Back to NUS overview · NUS holders · NUS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.